Kenneth A Larson

Title: Innovations of Kenneth A Larson

Introduction

Kenneth A Larson is an accomplished inventor based in Fort Collins, CO (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative drug delivery systems. With a total of 3 patents, Larson's work focuses on enhancing the efficacy and safety of pharmacologically active compounds.

Latest Patents

One of Larson's latest patents is titled "Phospholipid-coated microcrystals for the sustained release of pharmacologically active compounds and methods of their manufacture and use." This invention relates to pharmaceutical compositions designed for the sustained release of active compounds. The compositions feature microcrystals encapsulated within a unique phospholipid layer, which allows for varying sizes of microcrystals. At least 50 percent of these microcrystals range from 0.5 µm to 3.0 µm in diameter, with some exceeding 10 µm. The sustained release times achieved with this invention can last between 10 to 12 days, making it applicable for treating respiratory diseases, infections, inflammation, and pain in mammals. Additionally, the invention aims to reduce the toxicity of drug compounds.

Career Highlights

Throughout his career, Kenneth A Larson has worked with notable companies, including IDEXX Laboratories, Inc. His experience in the pharmaceutical industry has equipped him with the knowledge and skills necessary to innovate in drug delivery systems.

Collaborations

Larson has collaborated with esteemed colleagues such as William R Campbell and Douglas I Hepler. These partnerships have contributed to the advancement of his research and the successful development of his patents.

Conclusion

Kenneth A Larson's contributions to pharmaceutical innovations demonstrate his commitment to improving drug delivery systems. His work continues to impact the field positively, paving the way for more effective treatments.